Centrum Medyczne Dietla 19 Sp. z o.o.
- Address
- Ul. Jozefa Dietla 19/3, 31-070 Krakow, Poland
Centrum Medyczne Dietla 19 Sp. z o.o. - Ophthalmic Research Center
Centrum Medyczne Dietla 19 is a specialized clinical research center focused on advancing ophthalmic care through participation in international Phase III clinical trials. The center demonstrates particular expertise in evaluating novel therapeutic interventions for both pediatric and adult ocular conditions, with emphasis on retinal diseases and refractive disorders.
- Neovascular age-related macular degeneration (nAMD/wet AMD) - biosimilar and combination therapy studies
- Pediatric myopia progression treatment and prevention
- Thyroid eye disease management with novel biologic therapies
The center conducts rigorous comparative effectiveness studies, including biosimilar equivalence trials for anti-VEGF agents and combination therapy approaches for complex retinal conditions. Their research portfolio spans multiple ophthalmic subspecialties, from pediatric refractive management with atropine-based interventions to advanced intravitreal therapies for macular degeneration and systemic biologic treatments for thyroid-associated ophthalmopathy. This comprehensive approach positions the center at the forefront of translating innovative ophthalmic therapies into clinical practice.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Alvotech Swiss AG1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1F. Hoffmann-La Roche AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne Dietla 19 Sp. z o.o.
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomised, double-masked, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of oral BI 1815368 in participants with centre-involved diabetic macular edema for 48 weeks of treatment (THULITE) | Boehringer Ingelheim International GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aflibercept | 3 | Unknown | 2026-03-31 | 2026-06-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.